Versluis, D.J.

patient influenza vaccine vaccination haemodialysi response subject titre control hd patients booster protection component virus dialysis influenza vaccination booster vaccination vaccine components a-h 3n prevaccination titres study influenza vaccine group antibody prevaccination control subjects seroresponse number result difference booster immunisation 8 years a-h 1n effect duration table humoral response antibody response influenza b increase trivalent influenza vaccine protection rates value masurel netherland transplant humoral protection rate antigen influenza virus vaccine beyer injection failure rotterdam trivalent strain transplant patients immunogenicity immunization dialysis treatment 36-45 immunisation cohort treatment 98 hd patients dosage 101 hd patients day 0 march hepatitis b vaccine transplant recipients parameter uraemia volunteer hospital nonresponder recipient exclusion figure 1 epidemic influenza